Connect with us

Technology

RWS launches new linguistic validation service to significantly reduce clinical trial timelines

Published

on

New service brings critical eCOA trial services together under one program team to speed global studies

MAIDENHEAD, England, July 14, 2026 /PRNewswire/ — RWS (AIM: RWS.L), a global AI solutions company, today launched a new tech-enabled eCOA translation and linguistic validation service designed to help pharmaceutical companies, clinical research organizations (CROs) and eCOA providers reduce delays in global clinical trials.

The service brings together COA licensing, source validation, multilingual translation, Trados-enabled eCOA migration, intelligent workflows, rater training and dedicated program management under a single, integrated operating model – delivered by one program team with end-to-end governance and a single point of accountability across the entire COA lifecycle.

Global clinical trials depend on precise timing, and language is often one of the greatest pressure points. In a global study, every week counts: sponsors need to move from instrument access to eCOA go-live without putting study start-up, site activation or regulatory submissions at risk. Yet many organizations still manage licensing, translation, eCOA migration and rater training across multiple vendors, systems and disconnected workstreams. The result is familiar – handoffs multiply, accountability blurs, visibility narrows, and small delays compound into significant operational and regulatory risk.

RWS’s service addresses this by redesigning the delivery model around dedicated program management and intelligent workflows. A single leadership team owns planning, execution, communication, risk management and delivery at every stage, from licensing through to global deployment.

“Bringing eCOA translation, linguistic validation and rater training together under one program team is exactly the kind of service model global clinical trials need,” said Martial Marcotti, EVP & Chief Product Officer at Kayentis, a leading eCOA vendor. “Across many studies and therapeutic areas, we’ve come to rely on RWS as a trusted partner because they understand both the operational pressure sponsors face and the quality standards regulated research demands. An integrated approach like this can simplify global study execution, reduce handoffs and help sponsors move faster without compromising endpoint quality, compliance or the patient experience.”

As part of this transformation, RWS has expanded its digital health portfolio to include rater training, bringing together COA licensing, source validation, linguistic validation, eCOA migration, and rater training into one integrated delivery program. By removing traditional service silos, sponsors benefit from streamlined communication, consistent governance, simplified vendor management, and improved coordination from instrument acquisition through study execution.

“Clinical teams shouldn’t have to choose between speed and scientific standards,” said Dan Herron, Global Vice President, Digital Health at RWS. “For more than a decade, the industry has relied on fragmented delivery models for licensing, source validation, linguistic validation, eCOA migration and rater training. We’ve reimagined that approach by bringing every service together under a single program – creating a faster, more connected and more scalable model that helps sponsors reduce complexity, protect endpoint quality and accelerate global study execution.”

RWS is also investing in AI-powered tools and smart automation to augment subject matter experts – automating repetitive tasks, strengthening quality oversight and accelerating delivery while preserving the scientific rigor and regulatory compliance global research demands.

Click here to learn more.

About us

RWS is a global AI solutions company empowering the world’s most trusted enterprise AI.

Our proprietary Cultural Intelligence Layer, powered by 250,000 data specialists, cultural and language experts and deep domain professionals, backed by 45+ patents, makes enterprise AI culturally fluent, contextually accurate and secure, ensuring every interaction reflects a brand’s tone, context and customer values.

Through our Generate, Transform and Protect segments, we deliver intelligent content, enterprise knowledge, large-scale localization and IP protection for global growth. Trusted by 80+ of the world’s top 100 brands, RWS provides the confidence, governance and expertise organizations need to deploy AI safely, responsibly and at scale.

Headquartered in the UK, RWS is listed on AIM.

More information: rws.com.

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/rws-launches-new-linguistic-validation-service-to-significantly-reduce-clinical-trial-timelines-302824013.html

Continue Reading

Technology

Allooloo Tops 100M Capital Markets AI Agent Traffic a Month

Published

on

By

Agentic datasets on every listed company in 34 countries: sourced, dated and signed.

VANCOUVER, BC and LONDON, Nov. 20, 2026 /PRNewswire/ — Allooloo Technologies Corp. (Allooloo), maker of agentic datasets for capital markets artificial intelligence (AI) agents, today reported 100M AI agent traffic a month. That is 39 calls a second, 3.4 million a day, across getissuer.ai and Issuerwire.ai, running on 24 Microsoft Azure hyperscale locations globally with always-on Amazon Web Services (AWS) redundancy.

The Data Readiness Gap

Investment banks are not short of AI models. They are short of data an AI agent can use. In a 2026 Teradata study, 77% of technology leaders said 20% or less of their enterprise data is ready for AI agents. Banks are closing that gap on the data they hold, with one governed way in and the source, the date and the owner on every record.

The data a bank does not hold is the other half. An AI agent working on a security needs the issuer, its disclosures and whether it may be ordered, in every market the bank trades. Allooloo delivers that half agent-ready: 41.9K listed companies in 34 countries, a source and a date on every field, and a signed receipt for every read, over Model Context Protocol (MCP).

Two Products

Know Your Product (KYP) is the duty to know a security before it is recommended or sold. Allooloo KYP, at getissuer.ai, answers it for the AI agent: who the issuer is, whether it may be ordered, and who it is for. It covers 41.9K listed companies on 79 exchanges in 34 countries.

Issuerwire.ai is the dated disclosure wire: 3.1 million dated disclosures across 34 countries, each with its source.

Who it matters to:

Investment bank or dealer: its AI agents can show where each fact came from.The issuer: every AI agent reads the same answer about it.Compliance: a signed receipt for every cleared read.

A Signed Receipt for Every Read

Every cleared read on Allooloo leaves a signed receipt, the Record of Cleared Orders (RCO): what was read, when, and under which market’s rules.

Each Market in Its Own Country

Each market is kept in its own country or region, across 24 Microsoft Azure regions, on one MCP server per market. A second copy of every market is made each night on AWS and locked against deletion for 365 days. Allooloo is a Microsoft AI Cloud Partner.

Around the Clock

The products are made around the clock by Allooloo’s own team and AI agents, on the Allooloo Algo. AI agents call them around the clock and pay per call, with no seat and no licence.

“Today we are announcing a milestone: 100M AI agent traffic a month,” said Matthew Keddy, Chief Executive Officer of Allooloo Technologies Corp. “These are the AI agents of capital markets participants, and they want crisp data, five years deep, on 41.9K listed companies across 79 exchanges: sourced, dated and signed. Gain the edge with us.”

In Session and Enterprise Grade

Allooloo is sold two ways. In session, an AI agent calls Allooloo mid-task and pays as it goes (PayGo) on x402, the open payment standard for AI agents, with no seat and no licence. At enterprise grade, a firm licenses the datasets to design, build and run its own AI agents.

About Allooloo Technologies Corp.

Allooloo Technologies Corp. makes agentic capital markets data products for the AI agents of banks, dealers and issuers. Its products, getissuer.ai and Issuerwire.ai, cover 41.9K listed companies on 79 exchanges in 34 countries, kept across 24 Microsoft Azure regions with on-the-fly redundancy on Amazon Web Services (AWS). The result is always-on agentic datasets: in session for AI lab users, and enterprise grade for customers who design, build and run their own AI agents. Allooloo is headquartered in Vancouver, Canada. Please visit: allooloo.ai 

View original content:https://www.prnewswire.com/news-releases/allooloo-tops-100m-capital-markets-ai-agent-traffic-a-month-302947422.html

SOURCE Allooloo Technologies Corp.

Continue Reading

Technology

Allooloo Tops 100M Capital Markets AI Agent Traffic a Month

Published

on

By

Agentic datasets on every listed company in 34 countries: sourced, dated and signed.

VANCOUVER, BC and LONDON, Nov. 21, 2026 /PRNewswire/ — Allooloo Technologies Corp. (Allooloo), maker of agentic datasets for capital markets artificial intelligence (AI) agents, today reported 100M AI agent traffic a month. That is 39 calls a second, 3.4 million a day, across getissuer.ai and Issuerwire.ai, running on 24 Microsoft Azure hyperscale locations globally with always-on Amazon Web Services (AWS) redundancy.

The Data Readiness Gap

Investment banks are not short of AI models. They are short of data an AI agent can use. In a 2026 Teradata study, 77% of technology leaders said 20% or less of their enterprise data is ready for AI agents. Banks are closing that gap on the data they hold, with one governed way in and the source, the date and the owner on every record.

The data a bank does not hold is the other half. An AI agent working on a security needs the issuer, its disclosures and whether it may be ordered, in every market the bank trades. Allooloo delivers that half agent-ready: 41.9K listed companies in 34 countries, a source and a date on every field, and a signed receipt for every read, over Model Context Protocol (MCP).

Two Products

Know Your Product (KYP) is the duty to know a security before it is recommended or sold. Allooloo KYP, at getissuer.ai, answers it for the AI agent: who the issuer is, whether it may be ordered, and who it is for. It covers 41.9K listed companies on 79 exchanges in 34 countries.

Issuerwire.ai is the dated disclosure wire: 3.1 million dated disclosures across 34 countries, each with its source.

Who it matters to:

Investment bank or dealer: its AI agents can show where each fact came from.The issuer: every AI agent reads the same answer about it.Compliance: a signed receipt for every cleared read.

A Signed Receipt for Every Read

Every cleared read on Allooloo leaves a signed receipt, the Record of Cleared Orders (RCO): what was read, when, and under which market’s rules.

Each Market in Its Own Country

Each market is kept in its own country or region, across 24 Microsoft Azure regions, on one MCP server per market. A second copy of every market is made each night on AWS and locked against deletion for 365 days. Allooloo is a Microsoft AI Cloud Partner.

Around the Clock

The products are made around the clock by Allooloo’s own team and AI agents, on the Allooloo Algo. AI agents call them around the clock and pay per call, with no seat and no licence.

“Today we are announcing a milestone: 100M AI agent traffic a month,” said Matthew Keddy, Chief Executive Officer of Allooloo Technologies Corp. “These are the AI agents of capital markets participants, and they want crisp data, five years deep, on 41.9K listed companies across 79 exchanges: sourced, dated and signed. Gain the edge with us.”

In Session and Enterprise Grade

Allooloo is sold two ways. In session, an AI agent calls Allooloo mid-task and pays as it goes (PayGo) on x402, the open payment standard for AI agents, with no seat and no licence. At enterprise grade, a firm licenses the datasets to design, build and run its own AI agents.

About Allooloo Technologies Corp.

Allooloo Technologies Corp. makes agentic capital markets data products for the AI agents of banks, dealers and issuers. Its products, getissuer.ai and Issuerwire.ai, cover 41.9K listed companies on 79 exchanges in 34 countries, kept across 24 Microsoft Azure regions with on-the-fly redundancy on Amazon Web Services (AWS). The result is always-on agentic datasets: in session for AI lab users, and enterprise grade for customers who design, build and run their own AI agents. Allooloo is headquartered in Vancouver, Canada. Please visit: allooloo.ai 

Contact: Matthew Keddy, CEO. mk@allooloo.ai +1 647 237 7744

View original content:https://www.prnewswire.com/apac/news-releases/allooloo-tops-100m-capital-markets-ai-agent-traffic-a-month-302947427.html

SOURCE Allooloo Technologies Corp.

Continue Reading

Technology

Ziehm-Orthoscan Announces Executive Leadership Transition Following 18 Years of Significant Growth

Published

on

By

Ziehm-Orthoscan Announces CEO Transition and Executive Leadership Appointments

SCOTTSDALE, Ariz., Nov. 20, 2026 /PRNewswire-PRWeb/ — Ziehm-Orthoscan Inc., the leader in mobile C-arm imaging solutions, today announced an executive leadership transition as President and Chief Executive Officer Nelson Mendes prepares to step down on December 31, 2026, following 18 years of distinguished leadership.

Effective January 1, 2027, Travis Prikryl will assume the role of Chief Executive Officer, and Hogie Saunders will be appointed Chief Operating Officer. Both executives will also serve as Managing Directors of Ziehm-Orthoscan Inc.

Under Mendes’ leadership, Ziehm-Orthoscan experienced extraordinary growth and transformation, evolving from a small U.S. operation into a major contributor to the company’s global business. Since 2009, U.S. operations have grown from approximately six employees to nearly 200, reflecting Ziehm-Orthoscan’s significant expansion and continued investment. This growth includes the establishment of a new headquarters and production facility in Scottsdale, Arizona, which serves as the global center for the development and manufacturing of all Orthoscan mini C-arm systems.

A significant milestone in this transformation was the acquisition and integration of Orthoscan in 2015, bringing together Ziehm’s full-size mobile C-arm technology and Orthoscan’s mini C-arm expertise. This strategic expansion established a comprehensive mobile imaging portfolio, strengthened the company’s competitive position, and accelerated its growth throughout the U.S. healthcare market.

Throughout his tenure, Mendes championed innovation, operational excellence, and customer relationships, helping establish Ziehm-Orthoscan as a trusted imaging partner to healthcare institutions nationwide.

To ensure a seamless transition, Mendes will remain with the company as a full-time strategic advisor through March 31, 2027, followed by a part-time consulting role supporting the organization’s continued development.

The appointments of Travis Prikryl and Hogie Saunders represent the next chapter in Ziehm-Orthoscan’s long-term growth strategy. Together with the company’s experienced management team, they will focus on advancing imaging innovation, strengthening customer partnerships, expanding market opportunities, and building on the strong foundation established over the past 18 years.

Ziehm-Orthoscan extends its sincere appreciation to Nelson Mendes for his exceptional leadership and contributions while expressing full confidence in the incoming executive team to guide the organization into its next phase of growth and success.

About Ziehm-Orthoscan

Ziehm-Orthoscan is the leader of innovative mobile imaging solutions, combining Ziehm’s expertise in full-size mobile C-arms with Orthoscan’s specialized mini C-arm technology. The company is committed to advancing medical imaging through innovation, exceptional service, and solutions designed to meet the evolving needs of healthcare professionals.

Media Contact

Rich Shaul, Vice President Marketing, Ziehm-Orthoscan, Inc., 1 4805038010, marketing@ziehm-orthoscan.com, https://ziehm-orthoscan.com/

View original content to download multimedia:https://www.prweb.com/releases/ziehm-orthoscan-announces-executive-leadership-transition-following-18-years-of-significant-growth-302946604.html

SOURCE Ziehm-Orthoscan, Inc.

Continue Reading

Trending